Back to:
NHS Tayside

Polyendocrine Metabolic Ovarian Syndrome (PMOS) previously known as Polycystic Ovarian Syndrome (PCOS)

Warning

Who to refer

Consider routine referral if there is diagnostic uncertainty after initial assessment (unable to confirm 2 of 3 features).

Urgently

Presentation suggestive of androgen secreting tumour or non-classical Congenital Adrenal Hyperplasia (NC-CAH) or also known as late onset CAH.

  • Rapid virilisation (rapid onset: deepening voice, clitoromegaly, severe hirsutism, reduced breast size, increased muscle bulk)

  • Very high serum testosterone (> ~5 nmol/L or >2× upper limit of normal)

  • Suspected androgen-secreting ovarian/adrenal tumour on examination or imaging.

Who not to refer

  • Fertility difficulty –refer to fertility services

  • Menstrual problems –refer to gynaecology

  • Severe acne and/or problematic hirsutism –refer to dermatology

  • Obesity – refer to weight management services

How to refer

Referral to Endocrinology is via SCI-gateway


Specialty Description

Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is a common hormonal disorder in which there are higher than normal androgen levels which can lead to irregular menstrual periods, abnormal ovulation, infertility, excess facial or body hair and/or acne in women. It is often characterised by insulin resistance.

Diagnose PCOS in adults using the revised evidence-based Rotterdam approach (need 2 of 3):

  • Clinical/biochemical hyperandrogenism (see links below)

  • Ovulatory dysfunction

  • Polycystic ovarian morphology on ultrasound or elevated Anti-Mullerian Hormone) AMH


Primary Care Investigations

Investigations GPs should perform before referral (tailor to presentation):

  • Full history & exam: menstrual history, fertility desires, hair growth, acne, weight/BMI, BP, signs of virilisation.

  • Metabolic screening: fasting glucose or HbA1c; consider fasting lipids; BMI and BP

  • Hormones: total testosterone, FSH, LH, SHBG, TSH, prolactin.

  • Other tests: consider liver function tests; pregnancy test and fertility counselling if relevant.

Ultrasound: in adults, pelvic ultrasound (transvaginal or transabdominal)— but if clinical hyperandrogenism + irregular cycles are present, ultrasound is not required to make the diagnosis


Useful resources

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome | European Journal of Endocrinology | Oxford Academic

https://cks.nice.org.uk/topics/polycystic-ovary-syndrome/diagnosis/investigations/

Polycystic ovary syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice

Editorial Information

Last reviewed: 11/08/2026

Next review date: 11/08/2028

Reviewer name(s): Catriona Farrell - catriona.farrell@nhs.scot.